Quarles & Brady’s DEA Compliance & Litigation Practice Group is led by two former senior-level DEA attorneys who were very recently at the forefront of the largest enforcement actions and compliance initiatives undertaken by DEA, involving the diversion of pharmaceutical controlled substances and listed chemicals. As Quarles & Brady now employs the only practicing attorneys with substantial DEA compliance experience to leave DEA’s Office of Chief Counsel in nearly 20 years, the DEA compliance expertise at the firm is unmatched.
Our DEA Compliance & Litigation Practice Group helps members of the pharmaceutical and health care industry fulfill their obligations under the Controlled Substances Act (CSA) and DEA’s implementing regulations. Our attorneys are committed to developing our clients into industry leaders in DEA compliance while facilitating innovation in the delivery of controlled substances and listed chemicals throughout the supply chain.
DEA compliance is complex, costly, and not without substantial risk. Given the current regulatory environment, health care companies and organizations need the most effective and experienced legal representation available. The DEA Compliance & Litigation Practice Group at Quarles & Brady has been built to address the most comprehensive and complex needs of organizations that operate in the highly regulated pharmaceutical environment. We look forward to working together with you to fully address your individual objectives and concerns.